Pendleton KE, Chen B, Liu K, Hunter OV, Xie Y, Tu BP, et al
Mondays presentation at the ADA of the BELIEVE Phase 2 from Lilly (via acq
Short-term metreleptin treatment of patients with anorexia nervosa: rapid on-set of beneficial cognitive, emotional, and behavioral effects
This approach effectively removes barriers to treatment, promoting the wider adoption of GLP-1-based therapies within clinical practice
These bioactive compounds work by modulating cellular pathways that govern gut healing and homeostasis
#RegulatoryScience #DrugSafety #HospitalMedicine #CriticalCarePharma #RiskManagement #HealthcareCompliance #EvidenceBasedMedicine #MedicalInnovation To view or add a comment, sign in 17,747 followers